Immix Biopharma (IMMX) SEC Filings & 10K Form

$2.10
-0.03 (-1.41%)
(As of 04/25/2024 ET)

Recent Immix Biopharma SEC Filings

DateFilerForm TypeView
02/07/2024
4:15 PM
Immix Biopharma (Filer)
Form 424B5
02/07/2024
8:18 AM
HIRSCHMAN ORIN (Filed by)
Immix Biopharma (Subject)
Form SC 13G
02/06/2024
8:09 AM
Immix Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2024
3:37 PM
Immix Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2024
3:38 PM
Immix Biopharma (Filer)
Form 424B5
12/12/2023
5:25 PM
Hsu Jason (Reporting)
Immix Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
6:54 PM
Immix Biopharma (Issuer)
Rachman Ilya M (Reporting)
Form 4/A
11/09/2023
6:57 PM
Immix Biopharma (Issuer)
Morris Gabriel S (Reporting)
Form 4/A
09/28/2023
11:15 PM
Immix Biopharma (Filer)
Form EFFECT
09/25/2023
3:15 PM
Immix Biopharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/18/2023
6:03 PM
Hsu Jason (Reporting)
Immix Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
5:27 PM
Immix Biopharma (Issuer)
Ng Carey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
4:20 PM
Adams Helen C. (Reporting)
Immix Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
4:18 PM
BUCHAN MELISSA JANE (Reporting)
Immix Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2023
4:46 PM
Immix Biopharma (Issuer)
Marquet Magda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
3:33 PM
Immix Biopharma (Issuer)
Marquet Magda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
5:43 PM
Immix Biopharma (Issuer)
Marquet Magda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2023
3:15 PM
GKCC, LLC (Filed by)
Immix Biopharma (Subject)
Form SC 13D
08/23/2023
3:26 PM
Chudnovsky Yekaterina (Reporting)
Immix Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/23/2023
3:28 PM
Chudnovsky Yekaterina (Reporting)
Immix Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2023
4:26 PM
Immix Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2023
4:28 PM
Immix Biopharma (Filer)
Form 424B5
06/13/2023
4:27 PM
Immix Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/08/2023
5:05 AM
Immix Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2023
3:52 PM
Immix Biopharma (Filer)
Form DEF 14A
04/25/2023
3:57 PM
Immix Biopharma (Filer)
Form ARS
04/25/2023
3:58 PM
Immix Biopharma (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:IMMX) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners